Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancers.

Laia Paré,TomÃ¡s Pascual,Elia Seguí,María González-Cao,Cristina Teixidó,A. Rodriguez,Blanca Gonzalez-Farre,Miriam Cuatrecasas,Estela Pineda,Guillermo Crespo,Salvador Martin Algarra,Elisabeth Pérez-Ruíz,Begoña Mellado,J. Maurel,Javier Garcia Corbacho,Miguel Angel Molina-Vila,Josep M. Llovet,Noemi Reguart,Ana Arance,Aleix Prat

Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancers.

2018

3076Background: In advanced cancer, the overall response rate (ORR) following anti-PD1 monotherapy is variable (0% to 50%). Here, we hypothesized that this observation is partly explained by differ...

Keywords:

Cancer research
Pathology
Medicine
Messenger RNA
anti pd1
Oncology
advanced cancer
Internal medicine
overall response rate

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations